Published on December 18, 2009 at 1:08 AM
Roche Diagnostics (SWX:RO)
(SWX:ROG) (Pink Sheets: RHHBY) and Takara Bio (TSE Mothers: 4974),
the Shiga (Japan)-based supplier of systems for use in life science
research, announced that they have entered into a license agreement for
use of the melting curve analysis technology and SYBR Green
techniques in their Kits and Instruments for Real Time PCR. Under the
terms of the agreement, Takara obtains from Roche a non-exclusive
license for use on instruments in Japan, and a license for worldwide use
in kits, in the field of research applications. Financial terms of the
agreement were not disclosed.
Covered in the agreement are reagents and or methods using SYBR Green I
technology and melting curve analysis for real time PCR. This valuable
intellectual property portfolio has been extensively licensed by Roche
in cooperation with Idaho Technology, Inc.
“By licensing the PCR technique we contribute to the further development
of this technology in the life science research field,” states Manfred
Baier, Head of Roche Applied Science, a business area of Roche
Diagnostics.
The melting curve analysis is a technique for analysis of PCR products.
After PCR, the resulting PCR product is slowly heated. Each
double-stranded DNA has its own specific melting temperature (Tm),
which is defined as the temperature at which 50% of the DNA becomes
single stranded. By measurement of Tm, the DNA can be easily identified.
http://www.roche.com/